Investors are optimistic about Merit Medical's (MMSI) strong product portfolio.
Vous n'êtes pas connecté
Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
Investors are optimistic about Merit Medical's (MMSI) strong product portfolio.
In the latest trading session, McKesson (MCK) closed at $599.56, marking a -0.8% move from the previous day.
Emerson (EMR) is set to gain from strength in the Intelligent Devices business segment and the acquisitions of Afag and Flexim. Its measures to reward...
Apple's (AAPL) AI push, growing Services business and strong liquidity position make the shares attractive for investors.
Allegion (ALLE) benefits from strength in the Allegion International segment and accretive acquisitions. Its measures to reward its shareholders are...
Allegion (ALLE) benefits from strength in the Allegion International segment and accretive acquisitions. Its measures to reward its shareholders are...
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's...
Investors target stocks that have been on a bullish run lately. Stocks like AMKR, THC, LDOS and MMS that are seeing price strength have a high chance...
Investors are optimistic about Charles River (CRL) due to its business performance and strategic buyouts.
Based on the average brokerage recommendation (ABR), Adma Biologics (ADMA) should be added to one's portfolio. Wall Street analysts' overly optimistic...